InMed Pharmaceuticals Inc. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD from Q4 2020 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
InMed Pharmaceuticals Inc. annual/quarterly Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q4 2020 to Q1 2022.
  • InMed Pharmaceuticals Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending March 31, 2022 was $310K, a 29.2% decline year-over-year.
  • InMed Pharmaceuticals Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $1.37M, a 28.3% decline from 2021.
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $310K -$128K -29.2% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $265K -$11.7K -4.23% Oct 1, 2021 Dec 31, 2021 10-Q 2022-02-14
Q1 2021 $437K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $277K Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.